Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Group B Streptococcus (GBS) Alpha-like protein (Alp) family consists of several large, surface-anchored proteins, including Alpha C, Rib, Alp1, Alp2, Alp3, and Alp4 (Lindahl et al., 2005). These proteins are characterized by a conserved N-terminal domain and a variable number of tandem repeats, playing a crucial role in GBS virulence by mediating adhesion to host epithelial cells and facilitating immune evasion (Bolduc et al., 2002). The N-terminal domains are highly immunogenic and surface-exposed, making them primary targets for vaccine development aimed at preventing invasive GBS disease in neonates (Fischer et al., 2021). Therapeutic strategies, such as the GBS-NN vaccine candidate, utilize recombinant N-terminal domains to induce high titers of protective opsonophagocytic antibodies (Minervax, 2023). These antibodies bind to the bacterial surface, promoting phagocytosis and clearance by host immune cells, thereby providing broad protection against various GBS serotypes that express Alp family proteins (Donders et al., 2016).
Induction of opsonophagocytic antibodies that bind to the N-terminal domains of Alp proteins on the bacterial surface, facilitating phagocytosis and clearance by immune cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Group B Streptococcus Alpha-like protein family N-terminal domains (GBS Alp N-terminal domains).